Persistence of non-viral vector mediated RPE65 expression: case for viability as a gene transfer therapy for RPE-based diseases.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Controlled Release

• Publication date

  2013-12-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jconrel.2013.08.299PMID 24035979PMCID PMC3858392
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA.

  2013cited by this paper
• A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium.

  2013cited by this paper
• Optimization of hCFTR lung expression in mice using DNA nanoparticles.

  2012cited by this paper
• Comparative Analysis of DNA Nanoparticles and AAVs for Ocular Gene Delivery

  2012cited by this paper
• Gene therapy for Leber congenital amaurosis: advances and future directions

  2012cited by this paper
• Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.

  2012cited by this paper
• Direct gene transfer with compacted DNA nanoparticles in retinal pigment epithelial cells: expression, repeat delivery and lack of toxicity.

  2012cited by this paper
• DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice.

  2012cited by this paper
• Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage

  2011cited by this paper
• DNA Nanoparticles: Detection of Long-Term Transgene Activity in Brain using Bioluminescence Imaging

  2011cited by this paper
• Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor.

  2011cited by this paper
• Regeneration of Photopigment Is Enhanced in Mouse Cone Photoreceptors Expressing RPE65 Protein

  2011cited by this paper
• Nanoparticle-mediated gene transfer specific to retinal pigment epithelial cells.

  2011cited by this paper
• Nanoparticles for retinal gene therapy.

  2010cited by this paper
• Gene delivery to mitotic and postmitotic photoreceptors Via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa

  2010cited by this paper
• Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency

  2010cited by this paper
• Subretinal delivery of adeno-associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent mice

  2009influential reference
• An alternative pathway mediates the mouse and human cone visual cycle.

  2009cited by this paper
• A Partial Structural and Functional Rescue of a Retinitis Pigmentosa Model with Compacted DNA Nanoparticles

  2009cited by this paper
• Ocular Delivery of Compacted DNA-Nanoparticles Does Not Elicit Toxicity in the Mouse Retina

  2009cited by this paper
• Long-term transgene expression in the central nervous system using DNA nanoparticles.

  2009cited by this paper
• Human RPE65 Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year

  2009influential reference
• Safety and efficacy of gene transfer for Leber's congenital amaurosis.

  2008influential reference
• Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial

  2008influential reference
• Leber congenital amaurosis - a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture.

  2007cited by this paper
• Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo.

  2007cited by this paper
• Lentiviral Gene Transfer of Rpe65 Rescues Survival and Function of Cones in a Mouse Model of Leber Congenital Amaurosis

  2006cited by this paper
• Designing nonviral vectors for efficient gene transfer and long-term gene expression.

  2006cited by this paper
• Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles

  2006cited by this paper
• RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65-/- mice.

  2006cited by this paper
• Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis.

  2006cited by this paper
• Biological characterization of gene response in Rpe65‐/‐ mouse model of Leber's congenital amaurosis during progression of the disease

  2006cited by this paper
• Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles

  2006cited by this paper
• Pharmacological and rAAV Gene Therapy Rescue of Visual Functions in a Blind Mouse Model of Leber Congenital Amaurosis

  2005cited by this paper
• Performance of Genomic Bordering Elements at Predefined Genomic Loci

  2005cited by this paper
• RPE65 is the isomerohydrolase in the retinoid visual cycle.

  2005cited by this paper
• Downregulation of cone-specific gene expression and degeneration of cone photoreceptors in the Rpe65-/- mouse at early ages.

  2005cited by this paper
• Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA).

  2005cited by this paper
• Compacted DNA Nanoparticles Administered to the Nasal Mucosa of Cystic Fibrosis Subjects Are Safe and Demonstrate Partial to Complete Cystic Fibrosis Transmembrane Regulator Reconstitution

  2004cited by this paper
• Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65-/- knockout mouse eye results in limited rescue

  2004cited by this paper
• Exploiting a minimal system to study the epigenetic control of DNA replication: the interplay between transcription and replication

  2004cited by this paper
• From DNA structure to gene expression: mediators of nuclear compartmentalization and dynamics

  2004cited by this paper
• Nanoparticles of Compacted DNA Transfect Postmitotic Cells*

  2003cited by this paper
• Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung.

  2003cited by this paper
• Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo.

  2003cited by this paper
• Scaffold/Matrix Attachment Region Elements Interact with a p300-Scaffold Attachment Factor A Complex and Are Bound by Acetylated Nucleosomes

  2002cited by this paper
• Recovery of Visual Functions in a Mouse Model of Leber Congenital Amaurosis*

  2002cited by this paper
• An episomally replicating vector binds to the nuclear matrix protein SAF‐A in vivo

  2002cited by this paper
• High-performance liquid chromatography analysis of visual cycle retinoids.

  2000cited by this paper
• Isomerization of all-trans-retinol to cis-retinols in bovine retinal pigment epithelial cells: dependence on the specificity of retinoid-binding proteins.

  2000cited by this paper
• Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle

  1998cited by this paper
• Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis.

  1998cited by this paper
• An Atypical Homeodomain in SATB1 Promotes Specific Recognition of the Key Structural Element in a Matrix Attachment Region*

  1997cited by this paper
• Stress-induced duplex DNA destabilization in scaffold/matrix attachment regions.

  1997cited by this paper

• Shining light on CRISPR/Cas9 therapeutics for inherited retinal diseases.

  2025cites this paper
• Non-Viral Delivery Systems to Transport Nucleic Acids for Inherited Retinal Disorders

  2025cites this paper
• Nanotherapy for Neural Retinal Regeneration

  2025cites this paper
• Effective intravitreal gene delivery to retinal pigment epithelium with hyaluronic acid nanospheres

  2024cites this paper
• Non-viral gene therapy for Leber's congenital amaurosis: progress and possibilities.

  2024cites this paper
• Exploration: Nanoparticles in the Diagnosis and Treatment of Retinal Diseases

  2023cites this paper
• Gene Augmentation of CHM Using Non-Viral Episomal Vectors in Models of Choroideremia

  2023cites this paper
• Successful large gene augmentation of USH2A with non-viral episomal vectors

  2023cites this paper
• Every nano-step counts: a critical reflection on do’s and don’ts in researching nanomedicines for retinal gene therapy

  2023cites this paper
• Effective gene therapy of Stargardt disease with PEG-ECO/pGRK1-ABCA4-S/MAR nanoparticles

  2022cites this paper
• Minicircle Delivery to the Neural Retina as a Gene Therapy Approach

  2022cites this paper
• Nanoparticle-mediated gene therapy as a novel strategy for the treatment of retinoblastoma.

  2022cites this paper
• Directing the Way—Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery

  2022cites this paper
• Gene Therapy for Inherited Retinal Disease: Long-Term Durability of Effect

  2022cites this paper
• Mesoporous Silica-Based Nanoparticles as Non-Viral Gene Delivery Platform for Treating Retinitis Pigmentosa

  2022cites this paper
• The Landscape of Non-Viral Gene Augmentation Strategies for Inherited Retinal Diseases

  2021cites this paper
• Application Prospects for Synthetic Nanoparticles in Optogenetic Retinal Prosthetics

  2021cites this paper
• Intraperitoneal chromophore injections delay early-onset and rapid retinal cone degeneration in a mouse model of Leber congenital amaurosis.

  2021cites this paper
• The Ocular Gene Delivery Landscape

  2021cites this paper
• Physical and mechanical cues affecting biomaterial-mediated plasmid DNA delivery: insights into non-viral delivery systems

  2021cites this paper
• Gene Therapy to the Retina and the Cochlea

  2021cites this paper
• Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt disease in a mouse model.

  2020cites this paper
• Nanotechnology in regenerative ophthalmology.

  2019cites this paper
• DNA nanoparticles are safe and nontoxic in non-human primate eyes

  2018cites this paper
• Nanoparticles as Delivery Vehicles for the Treatment of Retinal Degenerative Diseases.

  2018cites this paper
• Optimizing Non-viral Gene Therapy Vectors for Delivery to Photoreceptors and Retinal Pigment Epithelial Cells.

  2018cites this paper
• Recent perspectives on the delivery of biologics to back of the eye

  2017influential citation
• Non-viral gene therapy: Gains and challenges of non-invasive administration methods.

  2016cites this paper
• Nanoparticle-motivated gene delivery for ophthalmic application.

  2016cites this paper
• Choroideremia research: Report and perspectives on the second international scientific symposium for choroideremia

  2016cites this paper
• Promising and delivering gene therapies for vision loss.

  2015cites this paper
• Usher syndrome: a review of the clinical phenotype, genes and therapeutic strategies

  2015cites this paper
• Micellization of N-dodecylglucosylamine and its interaction with DNA in the presence of carboxylic acid

  2015cites this paper
• Gene therapy using stem cells.

  2015cites this paper
• Genomic DNA nanoparticles rescue rhodopsin‐associated retinitis pigmentosa phenotype

  2015cites this paper
• Improvement in vision: a new goal for treatment of hereditary retinal degenerations

  2015cites this paper
• Biology and therapy of inherited retinal degenerative disease: insights from mouse models

  2015cites this paper
• Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

  2015cites this paper
• Lipid Nanoparticles for Ocular Gene Delivery

  2015cites this paper
• Nanoparticle-based technologies for retinal gene therapy.

  2015cites this paper
• Gene Therapy for PRPH 2-Associated Ocular Disease : Challenges and Prospects

  2014cites this paper
• Gene therapy for PRPH2-associated ocular disease: challenges and prospects.

  2014cites this paper
• Nanoparticle-Assisted Targeted Delivery of Eye-Specific Genes to Eyes Significantly Improves the Vision of Blind Mice In Vivo

  2014cites this paper
• Vesicle formation between single-chained cationic surfactant and plasmid DNA and its application in cell transfection

  2014cites this paper
• Gene therapy approaches to disease of the cornea and anterior chamber

  2014cites this paper